BVS Q1 2025 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena

BVSBioventus Inc.

$593M

Q1 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$124M-4.3% YoY

Gross Profit

$83M67.0% margin

Operating Income

$5M3.9% margin

Net Income

-$3M-2.1% margin

EPS (Diluted)

$-0.04

QoQ Revenue Growth

-19.4%

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$20M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$691M

Total Liabilities

$506M

Stockholders' Equity

$148M

Cash & Equivalents

$23M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$124M	$129M	-4.3%
Gross Profit	$83M	$88M	-6.0%
Operating Income	$5M	$5M	-1.2%
Net Income	-$3M	-$5M	+46.1%

Revenue Segments

U.S. Segment

$111M89%

International Segment

$13M11%

Geographic Segments

UNITED STATES

$111M89%

Non-US

$13M11%